10-Q Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 Q3 2017

Filing Information

Form Type	10-Q
Accession Number	`0001144204-17-057782`
Period End Date	20170930
Filing Date	20171109
Fiscal Year	2017
Fiscal Period	Q3
XBRL Instance	bpth-20170930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 65 Income Statement 56 Cash Flow Statement 50

Balance Sheet 65 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`Cash`	$8.85M	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$4.62M	USD	Point-in-time
Cash	`Cash`	$9.38M	USD	Point-in-time
Cash	`Cash`	$11.30M	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid drug product for testing	`PrepaidExpenseCurrent`	$376.00K	USD	Point-in-time
Prepaid drug product for testing	`PrepaidExpenseCurrent`	$653.00K	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$902.00K	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$511.00K	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.79M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$10.65M	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	100.06M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	95.64M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	95.64M	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$708.00K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	100.06M	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$999.00K	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$279.00K	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$94.00K	USD	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	$614.00K	USD	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	$720.00K	USD	Point-in-time
Technology licenses	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Technology licenses	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Less accumulated amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.69M	USD	Point-in-time
Less accumulated amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.57M	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$809.00K	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$929.00K	USD	Point-in-time
Total Assets	`Assets`	$7.32M	USD	Point-in-time
Total Assets	`Assets`	$12.20M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$69.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$121.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$969.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$634.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$12.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$12.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$767.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.05M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$3.20M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	-	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$2.91M	USD	Point-in-time
Total Liabilities	`Liabilities`	$3.96M	USD	Point-in-time
Total Liabilities	`Liabilities`	$767.00K	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 100,057 and 95,645 shares issued and outstanding, respectively	`CommonStockValue`	$100.00K	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 100,057 and 95,645 shares issued and outstanding, respectively	`CommonStockValue`	$96.00K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$40.28M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$43.44M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-36.99M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-32.13M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$6.55M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$8.24M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$7.32M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$12.20M	USD	Point-in-time

Income Statement 56 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	-	USD	3 Qtrs
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.58M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.52M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.31M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.09M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$893.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.29M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$681.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.71M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$6.80M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$6.81M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$2.48M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$2.99M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-6.81M	USD	3 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-2.99M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-2.48M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-6.80M	USD	3 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-1.42M	USD	3 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-2.37M	USD	3 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-1.42M	USD	1 Quarter
Loss on extinguishment of warrant liability	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on extinguishment of warrant liability	`GainsLossesOnExtinguishmentOfDebt`	$-440.00K	USD	3 Qtrs
Loss on extinguishment of warrant liability	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Loss on extinguishment of warrant liability	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$8.00K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$2.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$7.00K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$4.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$1.42M	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$1.94M	USD	3 Qtrs
Total other income	`NonoperatingIncomeExpense`	$1.43M	USD	3 Qtrs
Total other income	`NonoperatingIncomeExpense`	$2.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.86M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-5.38M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.47M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.57M	USD	1 Quarter
Deemed dividend related to warrant conversion	`PreferredStockDividendsAndOtherAdjustments`	-	USD	3 Qtrs
Deemed dividend related to warrant conversion	`PreferredStockDividendsAndOtherAdjustments`	$1.04M	USD	3 Qtrs
Deemed dividend related to warrant conversion	`PreferredStockDividendsAndOtherAdjustments`	-	USD	1 Quarter
Deemed dividend related to warrant conversion	`PreferredStockDividendsAndOtherAdjustments`	-	USD	1 Quarter
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.57M	USD	1 Quarter
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-5.89M	USD	3 Qtrs
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.47M	USD	1 Quarter
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-5.38M	USD	3 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.06	USD	3 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.06	USD	3 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	91.72M	shares	3 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	98.10M	shares	3 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	95.64M	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	100.06M	shares	1 Quarter

Cash Flow Statement 50 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-4.86M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-5.38M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.47M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.57M	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$121.00K	USD	3 Qtrs
Amortization	`AdjustmentForAmortization`	$120.00K	USD	3 Qtrs
Depreciation	`Depreciation`	$185.00K	USD	3 Qtrs
Depreciation	`Depreciation`	$31.00K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$675.00K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$550.00K	USD	3 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-1.42M	USD	3 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-2.37M	USD	3 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-1.42M	USD	1 Quarter
Loss on extinguishment of warrant liability	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on extinguishment of warrant liability	`GainsLossesOnExtinguishmentOfDebt`	$-440.00K	USD	3 Qtrs
Loss on extinguishment of warrant liability	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Loss on extinguishment of warrant liability	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Prepaid drug product for testing	`IncreaseDecreaseInPrepaidExpense`	$-364.00K	USD	3 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInPrepaidExpense`	$277.00K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-391.00K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$733.00K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-71.00K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-36.00K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.73M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.54M	USD	3 Qtrs
Purchases of furniture, fixtures & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$25.00K	USD	3 Qtrs
Purchases of furniture, fixtures & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$538.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-25.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-538.00K	USD	3 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$9.01M	USD	3 Qtrs
Net proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	3 Qtrs
Net proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$1.52M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.52M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$9.01M	USD	3 Qtrs
Net increase (decrease) in cash	`CashPeriodIncreaseDecrease`	$2.44M	USD	3 Qtrs
Net increase (decrease) in cash	`CashPeriodIncreaseDecrease`	$-4.75M	USD	3 Qtrs
Cash, beginning of period	`Cash`	$8.85M	USD	Point-in-time
Cash, beginning of period	`Cash`	$4.62M	USD	Point-in-time
Cash, beginning of period	`Cash`	$9.38M	USD	Point-in-time
Cash, beginning of period	`Cash`	$11.30M	USD	Point-in-time
Cash, end of period	`Cash`	$8.85M	USD	Point-in-time
Cash, end of period	`Cash`	$4.62M	USD	Point-in-time
Cash, end of period	`Cash`	$9.38M	USD	Point-in-time
Cash, end of period	`Cash`	$11.30M	USD	Point-in-time
Incremental fair value of warrant liability modification	`IncrementalFairValueOfWarrantLiabilityModification`	$797.00K	USD	3 Qtrs
Incremental fair value of warrant liability modification	`IncrementalFairValueOfWarrantLiabilityModification`	-	USD	3 Qtrs
Conversion of warrant liability to equity	`DebtConversionOriginalDebtAmount1`	-	USD	3 Qtrs
Conversion of warrant liability to equity	`DebtConversionOriginalDebtAmount1`	$175.00K	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.